Where can I read PFE's latest 10-K?

PFE's latest annual report, a 10-K, was filed on Feb 26, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.

When did PFE last file an 8-K?

On Aug 4, 2026 it furnished a press release headed “Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 4, 2026.

Are PFE insiders buying or selling?

Over the last 13 months insiders sold $135K in 2 sales and bought $3.0M in 3 purchases; 93 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: DAMICO JENNIFER B. (SVP & Controller) sold 3,278 shares on Aug 5, 2026 for $83K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.

How many SEC filings has PFE made?

6,596 filings are on EDGAR under the registrant records that have been Pfizer Inc., going back to 1994; 5,187 of them are insider ownership forms (Forms 3, 4, 5 and 144).

Share this page

PFE

$29.58+0.48%

as of close, Oct 16, 2026

☾ AH $29.58 +0.48%

Pfizer Inc.Stock · HealthcareS&P 500 0.2%Russell 1000 0.2%US Stock Market 0.2%Russell 3000 0.2%S&P 500 Equal Weight 0.2%MSCI World 0.2%MSCI ACWI 0.1%Emerging Markets 0.001%

PeersMRNALLYMDTUNHJNJTMO

PFE SEC filings (2026)

CIK 78003 · Pharmaceutical Preparations (SIC 2834) · incorporated in DE · fiscal year ends in December

6,596 filings on EDGAR since 1994 · 34 annual, 101 quarterly, 356 current · financial statements · earnings

Latest 10-K

Feb 26, 2026

fiscal year to Dec 31, 2025

Latest 10-Q

Aug 4, 2026

quarter to Jun 28, 2026

Latest 8-K

Aug 4, 2026

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Last earnings release

Aug 4, 2026

$0.77 vs $0.68 · ▲ 1.5%

Filings on file

6,596

since 1994, 5,187 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $135K in 2 sales and bought $3.0M in 3 purchases; 93 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Aug 12, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorBought · $1.0M · 38,000 sh	Bought	38,000	$26.34	$1.0M	429,173	Form 4
Aug 5, 2026Form 4	BLAYLOCK RONALD EDirectorBought · $999K · 39,231 sh	Bought	39,231	$25.46	$999K	66,938	Form 4
Aug 5, 2026Form 4	Buckley Mortimer JDirectorBought · $960K · 37,632 sh	Bought	37,632	$25.52	$960K	37,632	Form 4
Aug 5, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerSold · $83K · 3,278 sh	Sold	3,278	$25.40	$83K	28,611	Form 4
Jun 9, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerSold · $51K · 2,000 sh	Sold	2,000	$25.70	$51K	31,397	Form 4

Awards, exercises, withholding and plan purchases · 93 transactions

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Oct 13, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $2,014 · 71 sh	Award· Phantom Stock Units SSP	71	$28.37	$2,014	783,981	Form 4
Sep 30, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $599 · 21 sh	Award· Phantom Stock Units SSP	21	$28.52	$599	783,888	Form 4
Sep 25, 2026Form 4	NARAYEN SHANTANUDirectorAward · Phantom Stock Units · $50K · 1,743.983 sh	Award· Phantom Stock Units	1,743.983	$28.67	$50K	205,648.823	Form 4
Sep 25, 2026Form 4	Echevarria JosephDirectorAward · Phantom Stock Units · $46K · 1,613.185 sh	Award· Phantom Stock Units	1,613.185	$28.67	$46K	169,739.319	Form 4
Sep 25, 2026Form 4	SMITH JAMES CDirectorAward · Phantom Stock Units · $45K · 1,569.585 sh	Award· Phantom Stock Units	1,569.585	$28.67	$45K	187,210.086	Form 4
Sep 25, 2026Form 4	Quincey JamesDirectorAward · Phantom Stock Units · $39K · 1,351.587 sh	Award· Phantom Stock Units	1,351.587	$28.67	$39K	90,670.847	Form 4
Sep 25, 2026Form 4	Taraporevala CyrusDirectorAward · Phantom Stock Units · $37K · 1,307.987 sh	Award· Phantom Stock Units	1,307.987	$28.67	$37K	38,805.658	Form 4
Sep 25, 2026Form 4	Buckley Mortimer JDirectorAward · Phantom Stock Units · $37K · 1,307.987 sh	Award· Phantom Stock Units	1,307.987	$28.67	$37K	28,039.756	Form 4
Sep 15, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $606 · 22 sh	Award· Phantom Stock Units SSP	22	$27.55	$606	783,985	Form 4
Aug 31, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $598 · 21 sh	Award· Phantom Stock Units SSP	21	$28.46	$598	784,012	Form 4
Aug 14, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $589 · 22 sh	Award· Phantom Stock Units SSP	22	$26.79	$589	785,060	Form 4
Jul 31, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $600 · 24 sh	Award· Phantom Stock Units SSP	24	$25.01	$600	786,154	Form 4
Jul 15, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $596 · 24 sh	Award· Phantom Stock Units SSP	24	$24.82	$596	772,901	Form 4
Jul 9, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $2,037 · 84 sh	Award· Phantom Stock Units SSP	84	$24.25	$2,037	772,938	Form 4
Jun 30, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $602 · 25 sh	Award· Phantom Stock Units SSP	25	$24.08	$602	772,979	Form 4
Jun 26, 2026Form 4	NARAYEN SHANTANUDirectorAward · Phantom Stock Units · $50K · 2,058.46 sh	Award· Phantom Stock Units	2,058.46	$24.29	$50K	200,879.336	Form 4
Jun 26, 2026Form 4	Echevarria JosephDirectorAward · Phantom Stock Units · $46K · 1,904.076 sh	Award· Phantom Stock Units	1,904.076	$24.29	$46K	165,631.508	Form 4
Jun 26, 2026Form 4	SMITH JAMES CDirectorAward · Phantom Stock Units · $45K · 1,852.614 sh	Award· Phantom Stock Units	1,852.614	$24.29	$45K	182,886.001	Form 4
Jun 26, 2026Form 4	Quincey JamesDirectorAward · Phantom Stock Units · $39K · 1,595.307 sh	Award· Phantom Stock Units	1,595.307	$24.29	$39K	87,993.957	Form 4
Jun 26, 2026Form 4	Taraporevala CyrusDirectorAward · Phantom Stock Units · $37K · 1,543.845 sh	Award· Phantom Stock Units	1,543.845	$24.29	$37K	36,941.287	Form 4
Jun 26, 2026Form 4	Buckley Mortimer JDirectorAward · Phantom Stock Units · $37K · 1,543.845 sh	Award· Phantom Stock Units	1,543.845	$24.29	$37K	26,335.128	Form 4
Jun 15, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $598 · 23 sh	Award· Phantom Stock Units SSP	23	$26.00	$598	772,772	Form 4
May 29, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $602 · 23 sh	Award· Phantom Stock Units SSP	23	$26.18	$602	772,789	Form 4
May 15, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $608 · 24 sh	Award· Phantom Stock Units SSP	24	$25.33	$608	773,297	Form 4
Apr 30, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $587 · 22 sh	Award· Phantom Stock Units SSP	22	$26.70	$587	760,229	Form 4
Apr 23, 2026Form 4	Taraporevala CyrusDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	34,826.086	Form 4
Apr 23, 2026Form 4	SMITH JAMES CDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	178,111.302	Form 4
Apr 23, 2026Form 4	Quincey JamesDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	85,004.077	Form 4
Apr 23, 2026Form 4	NARAYEN SHANTANUDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	195,611.68	Form 4
Apr 23, 2026Form 4	Echevarria JosephDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	161,084.684	Form 4
Apr 23, 2026Form 4	Desmond-Hellmann SusanDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	45,635.605	Form 4
Apr 23, 2026Form 4	Buckley Mortimer JDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	24,391.124	Form 4
Apr 23, 2026Form 4	BLAYLOCK RONALD EDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	84,012.66	Form 4
Apr 23, 2026Form 4	LITTMAN DAN R.DirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	74,533.568	Form 4
Apr 23, 2026Form 4	NORA JOHNSON SUZANNE MDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	116,982.649	Form 4
Apr 23, 2026Form 4	Gottlieb ScottDirectorAward · Phantom Stock Units · $205K · 7,686.539 sh	Award· Phantom Stock Units	7,686.539	$26.67	$205K	57,001.814	Form 4
Apr 15, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $598 · 22 sh	Award· Phantom Stock Units SSP	22	$27.19	$598	760,070	Form 4
Apr 14, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $25K · 911 sh	Award· Phantom Stock Units SSP	911	$27.11	$25K	760,090	Form 4
Mar 31, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $590 · 21 sh	Award· Phantom Stock Units SSP	21	$28.08	$590	759,049	Form 4
Mar 27, 2026Form 4	NARAYEN SHANTANUDirectorAward · Phantom Stock Units · $50K · 1,849.112 sh	Award· Phantom Stock Units	1,849.112	$27.04	$50K	187,925.141	Form 4
Mar 27, 2026Form 4	Echevarria JosephDirectorAward · Phantom Stock Units · $46K · 1,710.429 sh	Award· Phantom Stock Units	1,710.429	$27.04	$46K	153,398.145	Form 4
Mar 27, 2026Form 4	SMITH JAMES CDirectorAward · Phantom Stock Units · $45K · 1,664.201 sh	Award· Phantom Stock Units	1,664.201	$27.04	$45K	170,424.763	Form 4
Mar 27, 2026Form 4	Quincey JamesDirectorAward · Phantom Stock Units · $39K · 1,433.062 sh	Award· Phantom Stock Units	1,433.062	$27.04	$39K	77,317.538	Form 4
Mar 27, 2026Form 4	Buckley Mortimer JDirectorAward · Phantom Stock Units · $37K · 1,386.834 sh	Award· Phantom Stock Units	1,386.834	$27.04	$37K	16,704.585	Form 4
Mar 27, 2026Form 4	Taraporevala CyrusDirectorAward · Phantom Stock Units · $37K · 1,386.834 sh	Award· Phantom Stock Units	1,386.834	$27.04	$37K	27,139.547	Form 4
Mar 13, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $43K · 1,630 sh	Award· Phantom Stock Units SSP	1,630	$26.58	$43K	759,400	Form 4
Mar 4, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerTax withholding · $22K · 826 sh	Tax withholding	826	$26.62	$22K	32,934	Form 4
Mar 3, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · $0 · 708,666 sh	Award	708,666	$0.00	$0	708,666	Form 4
Mar 3, 2026Form 4	Baum AndrewExecutive Vice PresidentAward · $0 · 303,151 sh	Award	303,151	$0.00	$0	303,151	Form 4
Mar 3, 2026Form 4	BOSHOFF CHRISTOFFELPresident, R&DAward · $0 · 259,844 sh	Award	259,844	$0.00	$0	259,844	Form 4
Mar 3, 2026Form 4	Denton David MChief Financial Officer & EVPAward · $0 · 216,537 sh	Award	216,537	$0.00	$0	216,537	Form 4
Mar 3, 2026Form 4	de Germay AlexandreExecutive Vice PresidentAward · $0 · 194,883 sh	Award	194,883	$0.00	$0	194,883	Form 4
Mar 3, 2026Form 4	MALIK AAMIRExecutive Vice PresidentAward · $0 · 194,883 sh	Award	194,883	$0.00	$0	194,883	Form 4
Mar 3, 2026Form 4	LANKLER DOUGLAS MExecutive Vice PresidentAward · $0 · 194,883 sh	Award	194,883	$0.00	$0	194,883	Form 4
Mar 3, 2026Form 4	McDermott MichaelExecutive Vice PresidentAward · $0 · 151,576 sh	Award	151,576	$0.00	$0	151,576	Form 4
Mar 3, 2026Form 4	SAHNI PAYALExecutive Vice PresidentAward · $0 · 108,268 sh	Award	108,268	$0.00	$0	108,268	Form 4
Mar 3, 2026Form 4	Fonseca LidiaExecutive Vice PresidentAward · $0 · 82,284 sh	Award	82,284	$0.00	$0	82,284	Form 4
Mar 3, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerAward · $0 · 22,638 sh	Award	22,638	$0.00	$0	22,638	Form 4
Mar 3, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerAward · $0 · 21,719 sh	Award	21,719	$0.00	$0	33,760	Form 4
Feb 27, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerTax withholding · $18K · 655 sh	Tax withholding	655	$27.65	$18K	12,041	Form 4
Feb 26, 2026Form 4	McDermott MichaelExecutive Vice PresidentTax withholding · $95K · 3,503 sh	Tax withholding	3,503	$27.10	$95K	74,308	Form 4
Feb 25, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorExercise or conversion · $16.6M · 491,626 sh	Exercise or conversion	491,626	$33.82	$16.6M	864,215	Form 4
Feb 25, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorTax withholding · $12.8M · 475,544 sh	Tax withholding	475,544	$26.92–$27.09	$12.8M	388,671	Form 4
Feb 25, 2026Form 4	LANKLER DOUGLAS MExecutive Vice PresidentExercise or conversion · $4.2M · 122,907 sh	Exercise or conversion	122,907	$33.82	$4.2M	282,186	Form 4
Feb 25, 2026Form 4	LANKLER DOUGLAS MExecutive Vice PresidentTax withholding · $3.2M · 119,009 sh	Tax withholding	119,009	$26.92–$27.09	$3.2M	163,177	Form 4
Feb 25, 2026Form 4	Fonseca LidiaExecutive Vice PresidentExercise or conversion · $1.9M · 56,888 sh	Exercise or conversion	56,888	$33.82	$1.9M	101,579	Form 4
Feb 25, 2026Form 4	SAHNI PAYALExecutive Vice PresidentExercise or conversion · $1.9M · 56,888 sh	Exercise or conversion	56,888	$33.82	$1.9M	82,816	Form 4
Feb 25, 2026Form 4	SAHNI PAYALExecutive Vice PresidentTax withholding · $1.5M · 55,149 sh	Tax withholding	55,149	$26.92–$27.09	$1.5M	27,667	Form 4
Feb 25, 2026Form 4	Fonseca LidiaExecutive Vice PresidentTax withholding · $1.5M · 55,124 sh	Tax withholding	55,124	$26.92–$27.09	$1.5M	46,455	Form 4
Feb 25, 2026Form 4	McDermott MichaelExecutive Vice PresidentExercise or conversion · $1.3M · 37,925 sh	Exercise or conversion	37,925	$33.82	$1.3M	114,534	Form 4
Feb 25, 2026Form 4	McDermott MichaelExecutive Vice PresidentTax withholding · $989K · 36,723 sh	Tax withholding	36,723	$26.92–$27.09	$989K	77,811	Form 4
Feb 25, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerExercise or conversion · $594K · 17,558 sh	Exercise or conversion	17,558	$33.82	$594K	29,744	Form 4
Feb 25, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerTax withholding · $459K · 17,048 sh	Tax withholding	17,048	$26.92–$27.09	$459K	12,696	Form 4
Feb 25, 2026Form 4	BOSHOFF CHRISTOFFELPresident, R&DTax withholding · $185K · 6,833 sh	Tax withholding	6,833	$27.09	$185K	161,379	Form 4
Feb 25, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorExercise or conversion · $0 · 491,626 sh	Exercise or conversion	491,626	$0.00	$0	0	Form 4
Feb 25, 2026Form 4	LANKLER DOUGLAS MExecutive Vice PresidentExercise or conversion · $0 · 122,907 sh	Exercise or conversion	122,907	$0.00	$0	0	Form 4
Feb 25, 2026Form 4	Fonseca LidiaExecutive Vice PresidentExercise or conversion · $0 · 56,888 sh	Exercise or conversion	56,888	$0.00	$0	0	Form 4
Feb 25, 2026Form 4	SAHNI PAYALExecutive Vice PresidentExercise or conversion · $0 · 56,888 sh	Exercise or conversion	56,888	$0.00	$0	0	Form 4
Feb 25, 2026Form 4	McDermott MichaelExecutive Vice PresidentExercise or conversion · $0 · 37,925 sh	Exercise or conversion	37,925	$0.00	$0	0	Form 4
Feb 25, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerExercise or conversion · $0 · 17,558 sh	Exercise or conversion	17,558	$0.00	$0	0	Form 4
Feb 25, 2026Form 4	BOSHOFF CHRISTOFFELPresident, R&DAward · $0 · 13,383 sh	Award	13,383	$0.00	$0	168,212	Form 4
Feb 23, 2026Form 4	BOSHOFF CHRISTOFFELPresident, R&DTax withholding · $22K · 816 sh	Tax withholding	816	$27.06	$22K	154,829	Form 4
Feb 23, 2026Form 4	DAMICO JENNIFER B.SVP & ControllerTax withholding · $11K · 419 sh	Tax withholding	419	$27.06	$11K	12,186	Form 4
Feb 12, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $79K · 2,883 sh	Award· Phantom Stock Units SSP	2,883	$27.47	$79K	757,286	Form 4
Jan 30, 2026Form 4	BOSHOFF CHRISTOFFELPresident, R&DTax withholding · $341K · 12,887 sh	Tax withholding	12,887	$26.44	$341K	155,645	Form 4
Jan 14, 2026Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $2,021 · 79 sh	Award· Phantom Stock Units SSP	79	$25.58	$2,021	743,136	Form 4
Dec 31, 2025Form 4	NARAYEN SHANTANUDirectorAward · Phantom Stock Units · $50K · 2,008.032 sh	Award· Phantom Stock Units	2,008.032	$24.90	$50K	183,164.359	Form 4
Dec 31, 2025Form 4	Echevarria JosephDirectorAward · Phantom Stock Units · $46K · 1,857.43 sh	Award· Phantom Stock Units	1,857.43	$24.90	$46K	149,314.146	Form 4
Dec 31, 2025Form 4	SMITH JAMES CDirectorAward · Phantom Stock Units · $45K · 1,807.229 sh	Award· Phantom Stock Units	1,807.229	$24.90	$45K	166,119.84	Form 4
Dec 31, 2025Form 4	Quincey JamesDirectorAward · Phantom Stock Units · $39K · 1,556.225 sh	Award· Phantom Stock Units	1,556.225	$24.90	$39K	74,697.055	Form 4
Dec 31, 2025Form 4	Taraporevala CyrusDirectorAward · Phantom Stock Units · $37K · 1,506.024 sh	Award· Phantom Stock Units	1,506.024	$24.90	$37K	25,349.741	Form 4
Dec 31, 2025Form 4	Buckley Mortimer JDirectorAward · Phantom Stock Units · $37K · 1,506.024 sh	Award· Phantom Stock Units	1,506.024	$24.90	$37K	15,078.063	Form 4
Dec 31, 2025Form 4	BOURLA ALBERTChairman & CEO · DirectorAward · Phantom Stock Units SSP · $598 · 24 sh	Award· Phantom Stock Units SSP	24	$24.90	$598	743,147	Form 4

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.

2026 · 12 filings

Filed	Form	What it is	Period
Aug 4, 202610-Q	10-Q	Quarterly report, Q2 2026 — revenue $15.03B (+3% y/y), net income −$248.0M, EPS −$0.04	Jun 28, 2026
Aug 4, 20268-K	8-K	Earnings release — EPS $0.77 vs $0.68 est. (+13.2%); revenue $15.03B (+3% y/y) 1.5%	Aug 4, 2026
Jun 18, 20268-K	8-K	Regulation FD disclosure	Jun 18, 2026
Jun 18, 20268-K	8-K	Pfizer Announces Chief Financial Officer TransitionDirectors or officers; compensation	Jun 18, 2026
May 5, 202610-Q	10-Q	Quarterly report, Q1 2026 — revenue $14.45B (+5% y/y), net income $2.69B, EPS $0.47	Mar 29, 2026
May 5, 20268-K	8-K	Earnings release — EPS $0.75 vs $0.71 est. (+5.6%); revenue $14.45B (+5% y/y) 0.6%	May 5, 2026
Apr 27, 20268-K	8-K	Shareholder vote results	Apr 23, 2026
Mar 12, 2026ARS	ARS	Annual report to shareholders	Dec 31, 2025
Mar 12, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Mar 12, 2026DEF 14A	DEF 14A	Proxy statement	Apr 23, 2026
Feb 26, 202610-K	10-K	Annual report, FY2025 — revenue $62.58B (−2% y/y), net income $7.77B, EPS $1.36	Dec 31, 2025
Feb 3, 20268-K	8-K	Earnings release — EPS $0.66 vs $0.57 est. (+15.8%); revenue $17.56B (−1% y/y) 3.3%	Feb 3, 2026

2025 · 22 filings

Filed	Form	What it is	Period
Dec 16, 20258-K	8-K	Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 GuidanceRegulation FD disclosure	Dec 16, 2025
Nov 21, 20258-K	8-K	Other events	Nov 18, 2025
Nov 13, 20258-K	8-K	Other events	Nov 13, 2025
Nov 4, 202510-Q	10-Q	Quarterly report, Q3 2025 — revenue $16.65B (−6% y/y), net income $3.54B, EPS $0.62	Sep 28, 2025
Nov 4, 20258-K	8-K	Earnings release — EPS $0.87 vs $0.66 est. (+31.8%); revenue $16.65B (−6% y/y) 1.5%	Nov 4, 2025
Aug 5, 202510-Q	10-Q	Quarterly report, Q2 2025 — revenue $14.65B (+10% y/y), net income $2.91B, EPS $0.51	Jun 29, 2025
Aug 5, 20258-K	8-K	Results of operations	Aug 5, 2025
May 19, 20258-K	8-K	Other events	May 14, 2025
May 5, 202510-Q	10-Q	Quarterly report, Q1 2025 — revenue $13.71B (−8% y/y), net income $2.97B, EPS $0.52	Mar 30, 2025
Apr 29, 20258-K	8-K	Results of operations; Exit or disposal costs	Apr 29, 2025
Apr 28, 20258-K	8-K	Shareholder vote results	Apr 24, 2025
Apr 11, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Apr 10, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Apr 10, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Apr 10, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Apr 7, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2025PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 13, 2025ARS	ARS	Annual report to shareholders	Dec 31, 2024
Mar 13, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Mar 13, 2025DEF 14A	DEF 14A	Proxy statement	Apr 24, 2025
Feb 27, 202510-K	10-K	Annual report, FY2024 — revenue $63.63B (+7% y/y), net income $8.03B, EPS $1.41	Dec 31, 2024
Feb 4, 20258-K	8-K	Results of operations	Feb 4, 2025

2024 · 26 filings

Filed	Form	What it is	Period
Dec 17, 20248-K	8-K	Regulation FD disclosure	Dec 17, 2024
Nov 4, 202410-Q	10-Q	Quarterly report, Q3 2024 — revenue $17.70B (+31% y/y), net income $4.46B, EPS $0.78	Sep 29, 2024
Oct 29, 20248-K	8-K	Results of operations	Oct 29, 2024
Oct 15, 20248-K	8-K	Directors or officers; compensation	Oct 10, 2024
Aug 5, 202410-Q	10-Q	Quarterly report, Q2 2024 — revenue $13.28B (+2% y/y), net income $41.0M, EPS $0.01	Jun 30, 2024
Jul 30, 20248-K	8-K	Results of operations	Jul 30, 2024
Jul 26, 20248-K	8-K	Directors or officers; compensation; Other events	Jul 24, 2024
Jul 10, 20248-K	8-K	Directors or officers; compensation	Jul 9, 2024
Jul 1, 20248-K	8-K	Directors or officers; compensation	Jun 27, 2024
May 22, 20248-K	8-K	Exit or disposal costs	May 22, 2024
May 8, 202410-Q	10-Q	Quarterly report, Q1 2024 — revenue $14.88B (−20% y/y), net income $3.12B, EPS $0.55	Mar 31, 2024
May 1, 20248-K	8-K	Results of operations	May 1, 2024
Apr 29, 20248-K	8-K	Shareholder vote results	Apr 25, 2024
Apr 16, 2024PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Apr 11, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Apr 11, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Apr 11, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Apr 9, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Mar 28, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Mar 28, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Mar 14, 2024ARS	ARS	Annual report to shareholders	Dec 31, 2023
Mar 14, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Mar 14, 2024DEF 14A	DEF 14A	Proxy statement	Apr 25, 2024
Feb 22, 202410-K	10-K	Annual report, FY2023 — revenue $59.55B (−35% y/y), net income $2.12B, EPS $0.37	Dec 31, 2023
Jan 30, 20248-K	8-K	Results of operations	Jan 30, 2024
Jan 10, 20248-K	8-K	Other events	Jan 10, 2024

2023 · 28 filings — 14 × 8-K, 4 × DEFA14A, 3 × 10-Q and 5 other forms

Filed	Form	What it is	Period
Nov 8, 202310-Q	10-Q	Quarterly report, Q3 2023 — revenue $13.49B (−40% y/y), net income −$2.38B, EPS −$0.42	Oct 1, 2023
Aug 9, 202310-Q	10-Q	Quarterly report, Q2 2023 — revenue $13.01B (−53% y/y), net income $2.33B, EPS $0.41	Jul 2, 2023
May 10, 202310-Q	10-Q	Quarterly report, Q1 2023 — revenue $18.49B (−28% y/y), net income $5.54B, EPS $0.97	Apr 2, 2023
Apr 12, 2023PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Apr 10, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Apr 10, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Apr 4, 2023PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 30, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Mar 22, 2023PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 17, 2023ARS	ARS	Annual report to shareholders	Dec 31, 2022
Mar 16, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Mar 16, 2023DEF 14A	DEF 14A	Proxy statement	—
Feb 23, 202310-K	10-K	Annual report, FY2022 — revenue $91.79B (+25% y/y), net income $31.37B, EPS $5.47	Dec 31, 2022

15 current reports (8-K) not listed; the year is on EDGAR.

2022 · 23 filings — 10 × 8-K, 5 × DEFA14A, 3 × 10-Q and 3 other forms

Filed	Form	What it is	Period
Nov 9, 202210-Q	10-Q	Quarterly report, Q3 2022 — revenue $22.64B (−6% y/y), net income $8.61B, EPS $1.51	Oct 2, 2022
Aug 10, 202210-Q	10-Q	Quarterly report, Q2 2022 — revenue $27.74B (+47% y/y), net income $9.91B, EPS $1.73	Jul 3, 2022
May 11, 202210-Q	10-Q	Quarterly report, Q1 2022 — revenue $25.66B (+77% y/y), net income $7.86B, EPS $1.37	Apr 3, 2022
Apr 22, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Apr 14, 2022PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Apr 11, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Apr 6, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Mar 30, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Mar 21, 2022PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 21, 2022PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 17, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Mar 17, 2022DEF 14A	DEF 14A	Proxy statement	Apr 28, 2022
Feb 24, 202210-K	10-K	Annual report, FY2021 — revenue $73.64B (+77% y/y), net income $21.98B, EPS $3.85	Dec 31, 2021

10 current reports (8-K) not listed; the year is on EDGAR.

2021 · 20 filings — 10 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Nov 12, 202110-Q	10-Q	Quarterly report, Q3 2021 — revenue $24.04B (+134% y/y), net income $8.15B, EPS $1.42	Oct 3, 2021
Aug 12, 202110-Q	10-Q	Quarterly report, Q2 2021 — revenue $18.90B (+92% y/y), net income $5.56B, EPS $0.98	Jul 4, 2021
May 13, 202110-Q	10-Q	Quarterly report, Q1 2021 — revenue $14.52B (+44% y/y), net income $4.88B, EPS $0.86	Apr 4, 2021
Apr 15, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Mar 29, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Mar 23, 2021PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 22, 2021PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 12, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Mar 12, 2021DEF 14A	DEF 14A	Proxy statement	Apr 22, 2021
Feb 25, 202110-K	10-K	Annual report, FY2020 — revenue $41.65B (+2% y/y), net income $9.16B, EPS $1.63	Dec 31, 2020

10 current reports (8-K) not listed; the year is on EDGAR.

2020 · 33 filings — 24 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Nov 5, 202010-Q	10-Q	Quarterly report, Q3 2020 — revenue $10.28B (−19% y/y), net income $1.47B, EPS $0.26	Sep 27, 2020
Aug 6, 202010-Q	10-Q	Quarterly report, Q2 2020 — revenue $9.86B (−26% y/y), net income $3.49B, EPS $0.62	Jun 28, 2020
May 7, 202010-Q	10-Q	Quarterly report, Q1 2020 — revenue $10.08B (−23% y/y), net income $3.35B, EPS $0.60	Mar 29, 2020
Apr 7, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Apr 6, 2020PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Apr 3, 2020PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 13, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Mar 13, 2020DEF 14A	DEF 14A	Proxy statement	Apr 23, 2020
Feb 27, 202010-K	10-K	Annual report, FY2019 — revenue $40.91B (+0% y/y), net income $16.03B, EPS $2.82	Dec 31, 2019

24 current reports (8-K) not listed; the year is on EDGAR.

2019 · 22 filings — 13 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Nov 7, 201910-Q	10-Q	Quarterly report, Q3 2019 — revenue $12.68B (−5% y/y), net income $7.68B, EPS $1.36	Sep 29, 2019
Aug 8, 201910-Q	10-Q	Quarterly report, Q2 2019 — revenue $13.26B (−2% y/y), net income $5.05B, EPS $0.89	Jun 30, 2019
May 9, 201910-Q	10-Q	Quarterly report, Q1 2019 — revenue $13.12B (+2% y/y), net income $3.88B, EPS $0.68	Mar 31, 2019
Apr 8, 2019PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Apr 2, 2019DEFA14A	DEFA14A	Additional proxy materials	—
Mar 21, 2019PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Mar 14, 2019DEFA14A	DEFA14A	Additional proxy materials	—
Mar 14, 2019DEF 14A	DEF 14A	Proxy statement	Apr 25, 2019
Feb 28, 201910-K	10-K	Annual report, FY2018 — revenue $40.83B (−22% y/y), net income $11.15B, EPS $1.87	Dec 31, 2018

13 current reports (8-K) not listed; the year is on EDGAR.

2018 · 21 filings — 12 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Nov 8, 201810-Q	10-Q	Quarterly report, Q3 2018 — revenue $13.30B (+1% y/y), net income $4.11B, EPS $0.69	Sep 30, 2018
Aug 9, 201810-Q	10-Q	Quarterly report, Q2 2018 — revenue $13.47B (+4% y/y), net income $3.87B, EPS $0.65	Jul 1, 2018
May 10, 201810-Q	10-Q	Quarterly report, Q1 2018 — revenue $12.91B, net income $3.56B, EPS $0.59	Apr 1, 2018
Apr 18, 2018PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Apr 6, 2018PX14A6G	PX14A6G	Shareholder exempt solicitation	—
Apr 6, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Mar 15, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Mar 15, 2018DEF 14A	DEF 14A	Proxy statement	Apr 26, 2018
Feb 22, 201810-K	10-K	Annual report, FY2017 — revenue $52.55B (−1% y/y), net income $21.31B, EPS $3.52	Dec 31, 2017

12 current reports (8-K) not listed; the year is on EDGAR.

2017 · 26 filings — 17 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Nov 9, 201710-Q	10-Q	Quarterly report, Q3 2017 — revenue $13.17B, net income $2.84B, EPS $0.47	Oct 1, 2017
Aug 10, 201710-Q	10-Q	Quarterly report, Q2 2017 — revenue $12.90B, net income $3.07B, EPS $0.51	Jul 2, 2017
May 11, 201710-Q	10-Q	Quarterly report, Q1 2017 — net income $3.12B, EPS $0.51	Apr 2, 2017
Apr 3, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Mar 16, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Mar 16, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Mar 16, 2017DEF 14A	DEF 14A	Proxy statement	Apr 27, 2017
Feb 23, 201710-K	10-K	Annual report, FY2016 — revenue $52.82B, net income $7.21B, EPS $1.17	Dec 31, 2016

18 current reports (8-K) not listed; the year is on EDGAR.

2016 · 25 filings — 16 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms

Counted, not listed; the year is on EDGAR.

2015 · 23 filings — 15 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Counted, not listed; the year is on EDGAR.

2014 · 21 filings — 13 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Counted, not listed; the year is on EDGAR.

2013 · 19 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2012 · 15 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2011 · 16 filings — 7 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms

Counted, not listed; the year is on EDGAR.

2010 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2009 · 27 filings — 21 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2008 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2007 · 22 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2006 · 26 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2005 · 21 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2004 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2003 · 22 filings — 13 × 8-K, 3 × 10-Q, 2 × 8-K/A and 4 other forms

Counted, not listed; the year is on EDGAR.

2002 · 11 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2001 · 10 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K405 and 1 other form

Counted, not listed; the year is on EDGAR.

2000 · 15 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K

Counted, not listed; the year is on EDGAR.

1999 · 16 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Counted, not listed; the year is on EDGAR.

1998 · 11 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K405 and 2 other forms

Counted, not listed; the year is on EDGAR.

1997 · 8 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

1996 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A

Counted, not listed; the year is on EDGAR.

1995 · 11 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

1994 · 8 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 98 filings — 82 × 4, 4 × SCHEDULE 13G/A, 3 × 13F-HR and 7 other forms

Filed	Form	What it is	Period
Oct 14, 20264	4	Insider transaction (Form 4)	Oct 13, 2026
Oct 1, 20264	4	Insider transaction (Form 4)	Sep 30, 2026
Sep 29, 20264	4	Insider transaction (Form 4)	Sep 25, 2026
Sep 29, 20264	4	Insider transaction (Form 4)	Sep 25, 2026
Sep 29, 20264	4	Insider transaction (Form 4)	Sep 25, 2026
Sep 29, 20264	4	Insider transaction (Form 4)	Sep 25, 2026
Sep 29, 20264	4	Insider transaction (Form 4)	Sep 25, 2026
Sep 29, 20264	4	Insider transaction (Form 4)	Sep 25, 2026
Sep 16, 20264	4	Insider transaction (Form 4)	Sep 15, 2026
Sep 1, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Aug 31, 2026N-PX	N-PX	Other filings	Jun 30, 2026
Aug 28, 20263	3	Initial insider holdings (Form 3)	Aug 17, 2026
Aug 17, 20264	4	Insider transaction (Form 4)	Aug 14, 2026
Aug 13, 202613F-HR	13F-HR	Other filings	Jun 30, 2026
Aug 12, 20264	4	Insider transaction (Form 4)	Aug 12, 2026
Aug 6, 20264	4	Insider transaction (Form 4)	Aug 5, 2026
Aug 5, 20264	4	Insider transaction (Form 4)	Aug 5, 2026
Aug 5, 20264	4	Insider transaction (Form 4)	Aug 5, 2026
Aug 3, 20264	4	Insider transaction (Form 4)	Jul 31, 2026
Jul 16, 20264	4	Insider transaction (Form 4)	Jul 15, 2026
Jul 13, 20264	4	Insider transaction (Form 4)	Jul 9, 2026
Jul 1, 20264	4	Insider transaction (Form 4)	Jun 30, 2026
Jun 30, 20264	4	Insider transaction (Form 4)	Jun 26, 2026
Jun 30, 20264	4	Insider transaction (Form 4)	Jun 26, 2026
Jun 30, 20264	4	Insider transaction (Form 4)	Jun 26, 2026

The newest 25 of 98 shown; the full year is on EDGAR.

2025 · 115 filings — 88 × 4, 5 × SCHEDULE 13D/A, 4 × 13F-HR and 11 other forms

Filed	Form	What it is	Period
Dec 17, 20254	4	Insider transaction (Form 4)	Dec 15, 2025
Dec 2, 20254	4	Insider transaction (Form 4)	Nov 28, 2025
Nov 20, 2025424B5	424B5	Prospectus supplement	—
Nov 19, 2025FWP	FWP	Free writing prospectus	—
Nov 18, 2025424B3	424B3	Prospectus	—
Nov 17, 20254	4	Insider transaction (Form 4)	Nov 14, 2025
Nov 13, 202513F-HR	13F-HR	Other filings	Sep 30, 2025
Nov 3, 20254	4	Insider transaction (Form 4)	Oct 31, 2025
Oct 17, 20254	4	Insider transaction (Form 4)	Oct 15, 2025
Oct 16, 20254	4	Insider transaction (Form 4)	Oct 14, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Oct 2, 20254	4	Insider transaction (Form 4)	Sep 30, 2025
Sep 17, 20254	4	Insider transaction (Form 4)	Sep 15, 2025
Sep 3, 20254	4	Insider transaction (Form 4)	Aug 29, 2025
Aug 19, 20254	4	Insider transaction (Form 4)	Aug 15, 2025
Aug 11, 202513F-HR	13F-HR	Other filings	Jun 30, 2025
Aug 4, 20254	4	Insider transaction (Form 4)	Jul 31, 2025
Jul 16, 20254	4	Insider transaction (Form 4)	Jul 14, 2025
Jul 2, 20254	4	Insider transaction (Form 4)	Jun 30, 2025
Jul 2, 20254	4	Insider transaction (Form 4)	Jun 30, 2025
Jul 2, 20254	4	Insider transaction (Form 4)	Jun 30, 2025

The newest 25 of 115 shown; the full year is on EDGAR.

2024 · 162 filings — 127 × 4, 9 × SC 13D/A, 9 × SC 13G/A and 10 other forms

Filed	Form	What it is	Period
Dec 17, 20244	4	Insider transaction (Form 4)	Dec 13, 2024
Dec 17, 20244	4	Insider transaction (Form 4)	Dec 13, 2024
Dec 2, 20244	4	Insider transaction (Form 4)	Nov 29, 2024
Dec 2, 20244	4	Insider transaction (Form 4)	Nov 29, 2024
Nov 18, 20244	4	Insider transaction (Form 4)	Nov 15, 2024
Nov 18, 20244	4	Insider transaction (Form 4)	Nov 15, 2024
Nov 1, 20244	4	Insider transaction (Form 4)	Oct 31, 2024
Nov 1, 20244	4	Insider transaction (Form 4)	Oct 31, 2024
Oct 31, 20244	4	Insider transaction (Form 4)	Oct 30, 2024
Oct 16, 20244	4	Insider transaction (Form 4)	Oct 15, 2024
Oct 16, 20244	4	Insider transaction (Form 4)	Oct 15, 2024
Oct 15, 20244	4	Insider transaction (Form 4)	Oct 10, 2024
Oct 15, 20243	3	Initial insider holdings (Form 3)	Oct 10, 2024
Oct 11, 20244	4	Insider transaction (Form 4)	Oct 10, 2024
Oct 11, 20244	4	Insider transaction (Form 4)	Oct 10, 2024
Oct 3, 2024SC 13D/A	SC 13D/A	Active holder above 5% (Schedule 13D), amended	—
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 2, 20244	4	Insider transaction (Form 4)	Sep 30, 2024
Oct 1, 2024SC 13D/A	SC 13D/A	Active holder above 5% (Schedule 13D), amended	—
Sep 16, 20244	4	Insider transaction (Form 4)	Sep 12, 2024

The newest 25 of 162 shown; the full year is on EDGAR.

2023 · 159 filings — 131 × 4, 7 × SC 13D/A, 5 × SC 13G/A and 10 other forms

Counted, not listed; the year is on EDGAR.

2022 · 167 filings — 138 × 4, 10 × SC 13G/A, 5 × 3 and 7 other forms

Counted, not listed; the year is on EDGAR.

2021 · 194 filings — 167 × 4, 8 × SC 13G/A, 5 × SC 13G and 10 other forms

Counted, not listed; the year is on EDGAR.

2020 · 217 filings — 185 × 4, 8 × 3, 7 × 425 and 8 other forms

Counted, not listed; the year is on EDGAR.

2019 · 227 filings — 179 × 4, 15 × 425, 8 × SC TO-T/A and 14 other forms

Counted, not listed; the year is on EDGAR.

2018 · 218 filings — 197 × 4, 7 × SC 13G/A, 5 × 3 and 7 other forms

Counted, not listed; the year is on EDGAR.

2017 · 179 filings — 155 × 4, 4 × NO ACT, 3 × 11-K and 11 other forms

Counted, not listed; the year is on EDGAR.

2016 · 245 filings — 181 × 4, 19 × 425, 7 × SC 13G/A and 15 other forms

Counted, not listed; the year is on EDGAR.

2015 · 233 filings — 184 × 4, 19 × 425, 5 × SC 13G and 14 other forms

Counted, not listed; the year is on EDGAR.

2014 · 239 filings — 214 × 4, 5 × 3, 4 × NO ACT and 9 other forms

Counted, not listed; the year is on EDGAR.

2013 · 428 filings — 345 × 4, 47 × 425, 9 × NO ACT and 14 other forms

Counted, not listed; the year is on EDGAR.

2012 · 279 filings — 258 × 4, 4 × CORRESP, 4 × NO ACT and 7 other forms

Counted, not listed; the year is on EDGAR.

2011 · 327 filings — 284 × 4, 10 × SC TO-T/A, 8 × CORRESP and 11 other forms

Counted, not listed; the year is on EDGAR.

2010 · 314 filings — 277 × 4, 6 × 3, 6 × NO ACT and 10 other forms

Counted, not listed; the year is on EDGAR.

2009 · 299 filings — 246 × 4, 12 × 425, 7 × NO ACT and 14 other forms

Counted, not listed; the year is on EDGAR.

2008 · 304 filings — 266 × 4, 7 × NO ACT, 6 × 3 and 10 other forms

Counted, not listed; the year is on EDGAR.

2007 · 285 filings — 242 × 4, 11 × NO ACT, 8 × 3 and 15 other forms

Counted, not listed; the year is on EDGAR.

2006 · 272 filings — 248 × 4, 9 × NO ACT, 5 × 3 and 6 other forms

Counted, not listed; the year is on EDGAR.

2005 · 249 filings — 227 × 4, 6 × NO ACT, 4 × SC 13D/A and 7 other forms

Counted, not listed; the year is on EDGAR.

2004 · 299 filings — 279 × 4, 3 × 11-K, 3 × 424B5 and 8 other forms

Counted, not listed; the year is on EDGAR.

2003 · 307 filings — 274 × 4, 6 × NO ACT, 6 × SC 13D and 8 other forms

Counted, not listed; the year is on EDGAR.

2002 · 120 filings — 84 × 4, 22 × 425, 4 × 11-K and 8 other forms

Counted, not listed; the year is on EDGAR.

2001 · 11 filings — 4 × 11-K, 3 × 424B2, 2 × S-8 and 2 other forms

Counted, not listed; the year is on EDGAR.

2000 · 13 filings — 4 × 425, 2 × 11-K, 2 × S-4/A and 4 other forms

Counted, not listed; the year is on EDGAR.

1999 · 7 filings — 2 × 11-K, 1 × 424B3, 1 × PRRN14A and 3 other forms

Counted, not listed; the year is on EDGAR.

1998 · 4 filings — 2 × 11-K, 1 × 497, 1 × S-8

Counted, not listed; the year is on EDGAR.

1997 · 5 filings — 2 × SC 13G/A, 1 × 424B3, 1 × 8-A12B and 1 other form

Counted, not listed; the year is on EDGAR.

1996 · 3 filings — 1 × S-8, 1 × SC 14D1, 1 × SC 14D1/A

Counted, not listed; the year is on EDGAR.

1995 · 1 filing — 1 × S-4

Counted, not listed; the year is on EDGAR.

1994 · 4 filings — 3 × S-8, 1 × S-3D

Counted, not listed; the year is on EDGAR.

About this data#

Pfizer Inc. (PFE) has 6,596 filings on EDGAR going back to 1994: 34 annual reports, 101 quarterly reports and 356 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 26, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Aug 4, 2026, furnished a press release headed “Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance”. Over the last 13 months insiders sold $135K in 2 sales and bought $3.0M in 3 purchases; 93 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Pfizer Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read PFE's latest 10-K?: PFE's latest annual report, a 10-K, was filed on Feb 26, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did PFE last file an 8-K?: On Aug 4, 2026 it furnished a press release headed “Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 4, 2026.
Are PFE insiders buying or selling?: Over the last 13 months insiders sold $135K in 2 sales and bought $3.0M in 3 purchases; 93 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: DAMICO JENNIFER B. (SVP & Controller) sold 3,278 shares on Aug 5, 2026 for $83K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has PFE made?: 6,596 filings are on EDGAR under the registrant records that have been Pfizer Inc., going back to 1994; 5,187 of them are insider ownership forms (Forms 3, 4, 5 and 144).

PFE SEC filings (2026)

What happened, last 12 months#

August 2026

June 2026

May 2026

April 2026

March 2026

February 2026

December 2025

November 2025

Insider transactions#

Reports and proxy statements#

Insider, ownership and other filings#

About this data#

FAQ#